Theses and Dissertations at Montana State University (MSU)
Permanent URI for this collectionhttps://scholarworks.montana.edu/handle/1/733
Browse
4 results
Search Results
Item Cancer processes probed by multivalency: investigations with galectin-3 and lactose functionalized dendrimers(Montana State University - Bozeman, College of Letters & Science, 2019) Fricke, Mackenzie Sue; Chairperson, Graduate Committee: Mary J. Cloninger; Samuel P. Bernhard was an author and Willy Totten, Katarina Achazi, Paul Hillman, Rainer Haag and Mary J. Cloninger were co-authors of the article, 'The toxicity, uptake, and impact on galectin-3 mediated apoptosis of lactose functionalized dendrimers' submitted to the journal 'Biomolecules special issue: moving forward with dendrimers' which is contained within this thesis.; Kyle Tweedy and Mary J. Cloninger were co-authors of the article, 'Lactose functionalized dendrimers impact galectin-3 mediated cancer cell migration in vitro' submitted to the journal 'ACS chemical biology' which is contained within this thesis.Cancer has become a prevalent disease that is the second leading cause of death in the United States. Various cancers have been identified as either over or under expressing a sugar binding protein: galectin-3. The target of this research is to investigate cancerous events that are impacted by galectin-3 and mediate these events through the use of a multivalent binding partner to galectin-3. This binding partner is lactose functionalized PAMAM dendrimers. Apoptosis has been reported as another phenomenon that galectin-3 impacts. By using a reporter assay, viability, cytotoxicity and apoptosis were observed for cancer cell line A549 in the presence of exogenously added galectin-3 and/or lactose functionalized dendrimers. It was found that exogenous galectin-3 and glycodendrimers did not have any significant impact on these cell viability tests. Therefore, glycodendrimers can be used to probe multivalent effects without threat of toxicity. Metastasis was investigated through a modified in vitro scratch assay. By monitoring the migration of cancer cells, it was found that exogenously added galectin-3 retarded cell migration. When glycodendrimers were included, migration was partially restored. This revealed the implications of exogenous galectin-3 regarding the metastatic potential of carcinomas. When the implications of the domains of galectin-3 were investigated, it was found that the truncated galectin-3 containing only the carbohydrate recognition domain (CRD) was unable to replicate the same effects observed in full length galectin-3. Immunofluorescence microscopy was used to locate the multivalent binding partner and galectin-3 in the assay. While endocytosis of galectin-3 was observed, no colocalization with the multivalent binding partner was observed intracellularly, supporting the hypothesis of an extracellular interaction mediating the results. Multivalent interactions between glycodendrimers and galectin-3 impacted cellular migration. Angiogenesis revealed that exogenous galectin-3 induced neovascularization. Glycodendrimers impacted galectin-3 mediated angiogenesis. Glycodendrimers alone could elicit effects either enhancing or negating angiogenesis depending on the dendrimer generation. Fluorescent tags revealed glycodendrimer accumulation on or inside the cells and galectin-3 on the surface of cell groups. Overall, these studies show that glycodendrimers can interact multivalently and affect cellular processes.Item Heterologous expression of laminin peptide 11 on a virus particle surface for use in malignant tumor cell targeting(Montana State University - Bozeman, College of Letters & Science, 2000) Arnold, Thomas DarmodyItem Novel compounds inhibiting HIV infection, breast cancer metastasis, and bacterial growth(Montana State University - Bozeman, College of Letters & Science, 2012) Shepard, Joyce Brewer; Chairperson, Graduate Committee: Martin Teintze; Royce A. Wilkinson, Jean R. Starkey and Martin Teintze were co-authors of the article, 'Novel compounds containing multiple guanide groups that inhibit breast cancer metastases' in the journal 'International journal for cancer research' which is contained within this thesis.; Royce A. Wilkinson was a main author, and Cassidy Cooper, Sarah K. Walton, Amanda R. Radke, Robert L. Watkins, Thomas J. Wright, Elizabeth Erikson, Mohamed E. Labib, Jovanka M. Voyich, and Martin Teintze were co-authors of the article, 'Broad-spectrum antibacterial activity in novel compounds containing multiple phenylguanide or biguanide groups' in the journal 'Journal of antimicrobial chemotherapy' which is contained within this thesis.We synthesized novel guanide, biguanide, phenylguanide, and naphthyguanide derived compounds on linear, branched, and dendrimer backbones that are effective inhibitors of HIV infection, breast cancer metastasis, and bacterial growth. HIV utilizes CXCR4 as a co-receptor for cellular entry. Blocking CXCR4 inhibits infection with X4 strains of the virus. Initial competition assays demonstrated that some of the phenylguanide compounds bound to CXCR4 with high affinity. The derivatives with high CXCR4 affinity inhibited X4 viral infection, but did not inhibit R5 or X4R5 viruses. Importantly, many cancers overexpress CXCR4, including breast cancer. CXCR4 activation leads to cellular chemotaxis, angiogenesis, and cell survival, all of which promote cancer survival and proliferation. Compounds with high CXCR4 affinity were evaluated for inhibition of breast cancer metastasis. In vitro toxicity of all the derivatives was determined, followed by in vitro migration inhibition. Three derivatives with the best selectivity indexes for CXCR4 were examined in an in vivo lung colony metastasis assay. Spermidine trisphenylguanide (SI = 1785) was evaluated at 50 micrometers, 200 micrometers, and 300 micrometers and showed increasing inhibition of lung metastases (P = 0.34, 0.3, 0.02, respectively). Spermidine bis-2-naphthylguanide (SI = 1230) and spermine tris-2-naphthylguanide (SI = 191) were evaluated at 100 micrometers and showed significant reduction of lung metastases (P = 0.1 and 0.04, respectively). The topical antiseptic biguanide chlorhexidine, is structurally similar to our derivatives. So, the derivatives were tested for antimicrobial activity against drug susceptible and resistant pathogenic Enterococcus, Staphylococcus, Acinetobacter, and Pseudomonas strains. THAM trisphenylguanide, DNT2300 biguanide and phenylguanide, and DNT2200 phenylguanide demonstrated broad spectrum bacteriocidal activity similar to chlorhexidine. Preliminary in vivo studies on mice treated with THAM trisphenylguanide either immediately after methicillin resistant Staphylococcus aureus (MRSA) infection or an hour post MRSA infection showed significant reductions in bacterial burden in the intraperitoneal cavity, heart and kidney in the immediate treatment group and slight reductions of bacterial burden in the one hour treatment group. This data shows the potential for treatment of MRSA infections with the tested compounds. Thus, different subsets of the novel guanide compounds discussed here can inhibit HIV infection, breast cancer metastasis, and bacterial growth.Item Structural investigations of the cancer-associated laminin binding protein and Nos L : a novel copper binding protein(Montana State University - Bozeman, College of Letters & Science, 2005) Taubner, Lara Marie; Chairperson, Graduate Committee: Valerie CopieThis thesis consists of two distinct projects, one on the metastasis-associated laminin binding protein and the other on the putative copper chaperone NosL, both related by the common aim of investigation of the relationship between protein structure and function using nuclear magnetic resonance techniques. In the first part of this dissertation, the role that the metastasis-associated laminin binding protein or LBP plays in the spread and development of cancer was investigated. Functional domains of LBP were delineated by limited proteolysis, overexpressed, and then assayed for their ability to bind to the previously identified in vivo binding partner laminin. These assays demonstrated that, at least under the conditions used in this assay, binding to laminin was localized to domain 137-230, a region that encompasses a previously identified binding site known as Peptide G. This protein, like the full-length recombinant laminin binding protein, aggregated under conditions used for nuclear magnetic resonance experiments and therefore could not be analyzed with this technique. Contrary to previous findings on a synthetic peptide corresponding to residues 205-229, this sequence within the context of the 200-295 construct demonstrated no laminin binding activity. Furthermore, the peptide lacked the predicted alpha-helical content and tertiary structure as ascertained by nuclear magnetic resonance and by circular dichroism spectroscopy. A potential role for the disorder exhibited by this region of LBP is proposed, and suggests possible new functions for the laminin binding protein in angiogenesis. NosL, the subject of the second part of this thesis, is a highly conserved copper(I) binding lipoprotein encoded by the nitrous oxide reductase (nos) gene cluster of denitrifying bacteria. To identify functional features and structural homologues of this protein, the structure of apo NosL Was solved using nuclear magnetic resonance techniques. The high-resolution structure of NosL consists of one four-strand antiparallel beta sheet, one three strand antiparallel beta sheet and two alpha-helices organized in a twisted butterfly-like fold that is structurally homologous to MerB, an alkyl mercury lyase. Chemical perturbation mapping performed on the copper(I)=protein defined regions of NosL potentially involved in copper binding, and thus allowed preliminary identification of the copper-binding ligand Met 109.